IperionX Files Quarterly Report on Form 6-K
Ticker: IPX · Form: 6-K · Filed: Jul 25, 2024 · CIK: 1898601
| Field | Detail |
|---|---|
| Company | Iperionx LTD (IPX) |
| Form Type | 6-K |
| Filed Date | Jul 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: quarterly-report, 6-k
TL;DR
IperionX dropped its Q-report, check the 6-K for the latest numbers.
AI Summary
IperionX Limited filed a Form 6-K on July 25, 2024, to report its quarterly results. The filing includes Exhibit 99.1, which is the Quarterly Report. The company's principal executive offices are located at 129 W Trade Street, Suite 1405, Charlotte, North Carolina.
Why It Matters
This filing provides investors with an update on IperionX's financial performance and operational status for the recent quarter.
Risk Assessment
Risk Level: low — This is a routine filing of quarterly results and does not contain significant new risk factors.
Key Players & Entities
- IperionX Limited (company) — Registrant
- July 25, 2024 (date) — Filing Date
- 129 W Trade Street, Suite 1405, Charlotte, North Carolina (location) — Principal Executive Offices
- 001-41338 (other) — SEC File Number
FAQ
What type of report is being filed?
A Form 6-K report is being filed.
What is the filing date of this report?
The filing date is July 25, 2024.
Where are IperionX Limited's principal executive offices located?
The principal executive offices are located at 129 W Trade Street, Suite 1405, Charlotte, North Carolina.
What is included as an exhibit in this Form 6-K?
Exhibit 99.1, the Quarterly Report, is filed as part of this Form 6-K.
Does IperionX file under Form 20-F or 40-F?
The registrant indicates it files annual reports under cover of Form 20-F.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 14.5 · Accepted 2024-07-25 09:46:53
Filing Documents
- ef20033065_6k.htm (6-K) — 9KB
- ef20033065_ex99-1.htm (EX-99.1) — 171KB
- image00001.jpg (GRAPHIC) — 136KB
- image00002.jpg (GRAPHIC) — 4KB
- image00003.jpg (GRAPHIC) — 8KB
- image00004.jpg (GRAPHIC) — 9KB
- image00005.jpg (GRAPHIC) — 8KB
- image00006.jpg (GRAPHIC) — 47KB
- 0001140361-24-034121.txt ( ) — 472KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 Date: July 25, 2024 Commission File Number: 001-41338 IperionX Limited (Translation of registrant's name into English) 129 W Trade Street, Suite 1405 Charlotte, North Carolina (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX The following exhibits are filed as part of this Form 6-K: Exhibit Description 99.1 Quarterly Report SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IPERIONX LIMITED (registrant) Date: July 25, 2024 By: /s/ Marcela Castro Name: Marcela Castro Title: Chief Financial Officer